Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 3,973-3,984 of 9,138
Drug study icon
OngoingEUCTR 2019-003623-37

CANnabidiol for Parkinson’s Disease Psychosis

This study is ongoing. It focuses on schizophrenia and currently lists study information in the United Kingdom.

In United Kingdom
SchizophreniaOther
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
Drug study icon
CompletedNCT02504151

Cannabidiol Treatment in people with Early Psychosis

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

Multiple locations, including New Haven
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Other study type icon
CompletedNCT01853020

Cannabinoids and Cerebellar-Motor Functioning

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

In West Haven
SchizophreniaOtherFrom 21 Years to 35 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Other study type icon
WithdrawnNCT00397605

Cannabinoids in Bipolarity

This study has public registry information. It focuses on bipolarity and currently lists study information in Canada.

In Vancouver
BipolarityOtherFrom 19 Years to 60 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity
Other study type icon
Active Not RecruitingNCT02407808

Cannabinoids, Learning, and Memory

This study is active but not recruiting. It focuses on schizophrenia and currently lists study information in the United States.

In West Haven
SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Other study type icon
TerminatedNCT03608137

Cannabis and Thought Disorder in Schizophrenia

This study has public registry information. It focuses on schizophrenia and currently lists study information in France.

In Bron
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia